Farmak is a finished-dose manufacturer based in Czech Republic. It holds 6 active US drug master files across a filed portfolio of 13 molecules. Its filings concentrate with NCELS (KZ), RAMA (GE) and JFDA (JO). Its GMP standing is certified by INVIMA (CO), MHRA (UK) and NCELS (KZ), among 7 authorities.
| Site | FDA FEI |
|---|---|
| Kyiv, United Arab Emirates | Not on file |
| Region De Moscu, Colombia | Not on file |
| Saint Petersburg, Colombia | Not on file |
| San Petesburgo, Colombia | Not on file |
| Vladimir Region, Colombia | Not on file |
| Barcelona, Spain | Not on file |
2 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| ブロムフェナクナトリウム | PMDA (Japan) | 2 |
| Adenosine | SFDA (Saudi Arabia) | 1 |
| Brimonidine | US FDA | 1 |
| Butamirate | SFDA (Saudi Arabia) | 1 |
| Dofetilide | US FDA | 1 |
| Regadenoson | US FDA | 1 |
| Tizanidine | US FDA | 1 |
| Warfarin | US FDA | 1 |
| Zolpidem | US FDA | 1 |
| チザニジン塩酸塩（製造専用） | PMDA (Japan) | 1 |
| ブリモニジン酒石酸塩 | PMDA (Japan) | 1 |
| 酒石酸ゾルピデム | PMDA (Japan) | 1 |
| Ａｄｅｎｏｓｉｎｅ，Ｔｅｓｔｅｄｍｉｃｒｏｂｉｏｌｏｇｉｃａｌｌｙａｎｄｆｏｒｐｙｒｏｇｅｎｓ | PMDA (Japan) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NCELS (KZ) | 139 | 2 |
| RAMA (GE) | 16 | None |
| JFDA (JO) | 16 | None |
| FAMHP (BE) | 15 | None |
| EMA | 13 | 1 |
| EEC_EAEU | 13 | None |
| INVIMA (CO) | None | 3 |
| MHRA (UK) | None | 2 |
| AEMPS (ES) | None | 1 |
| UZPHARM (UZ) | None | 1 |
| MINPROMTORG (RU) | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Farmak comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.